Response Biomedical Hits Key Milestone in 3M Collaboration for Infection Prevention
24-Aug-2005
"Hospital acquired infections are a tremendous burden on the health care system costing almost US$10 billion per year in the US alone, and result in approximately 12,000 deaths annually," stated Bill Radvak, President & CEO.
Organizations
3M
Response Biomedical
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Oxford Biomedica broadens 5T4 antibody collaboration with Pfizer
Go to page
NovaXS Biotech - Trabuco Canyon, USA
Go to page
Intercell's Japanese Encephalitis vaccine safe in Phase III trials
Go to page
Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody
Go to page
List_of_lymantriid_genera:I
Go to page
Celsius® FT100 | Freezing systems | Sartorius
Go to page
List_of_arctiid_genera:_I
Go to page
List_of_hesperiid_genera:X
Go to page
Diazepam
Go to page
List_of_gelechiid_genera:_X
Go to page
Dexamethasone
Go to page
List_of_lycaenid_genera:_T
Go to page